Implantable cardioverter-defibrillator

Results 181 to 190 of about 96,798 (264)

QT Interval Evaluation in Right Ventricular Pacing: Validation of a Novel Formula

Pacing and Clinical Electrophysiology, Volume 49, Issue 10, Page 1455-1463, October 2026.
ABSTRACT Background QT interval measurement in the presence of right ventricular pacing (RVP) represents a clinical challenge. We therefore aimed to derive and validate a formula for QT estimation during RVP in a large cohort of pacemaker patients. Methods and Results We prospectively enrolled 100 patients in a derivation cohort and 487 in a validation
Amr Abdin +9 more
wiley +1 more source

Identifying sleep profiles in patients with an implantable cardioverter-defibrillator: associations with psychological distress

Ladina Nager +10 more
openalex +1 more source

Safety and Performance of INVICTA DF4 Ventricular Defibrillation Lead: Results From APOLLO Prospective Multicenter Study

Pacing and Clinical Electrophysiology, Volume 49, Issue 10, Page 1595-1603, October 2026.
ABSTRACT Background Implantable cardioverter‐defibrillator (ICD) therapy relies on reliable right ventricular leads for pacing, sensing, and defibrillation. The INVICTA DF4 lead is an active‐fixation, quadripolar design intended to optimize implant workflow and long‐term safety and performance. Methods APOLLO was a prospective, multicenter, single‐arm,
Klaus K. Witte +13 more
wiley +1 more source

Relationship between Uncertainty and Health-related Quality of Life in Patients with Implantable Cardioverter-Defibrillators: Mediating Effect of Self-care Competence [PDF]